2018 Speakers



Appreciated how well organized the meeting was and the high calibre and diversity of talks

Chief, Structural Informatics Unit, Laboratory of Infectious Diseases, NIH


Dr Sunil Advani, Associate Professor, Director Division of Basic Science Research Department of Radiation Medicine & Applied Sciences, U.C. San Diego Moores Cancer Center

Sia Anagnostou, Sr. Director, Corporate Communications, Immunomic Therapeutics

Dr David Anderson, CSO, VBI Vaccines

Dr Charles Andres, Associate, Wilson, Sonsini, Goodrich & Rosati

Dr Ron Babecoff, Founder, President & CEO, BiondVax Pharmaceuticals Ltd

Dr Sean Bennett, Senior Director of Clinical Development and Medical Affairs, PaxVax Inc

Dr Scott Berry, President & Senior Statistical Scientist, Berry Consultants

Dr Zachary Bornholdt, Director, Antibody Discovery, Mapp Biopharmaceuticals

Dr Kara Bortone, Head JLABS San Diego, Johnson & Johnson Innovation, California-JJDC, Inc

Dr Jean Boyer, Senior Director of Analytical Sciences, Inovio Pharmaceuticals

Robb Butler, Former Programme Manager, Social Scientist, Who

Dr Tony Byers, Director Translational Sciences/VaxDesign, Sanofi Pasteur

Dr Corey Carter, President and Chief Executive Officer, EpicentRx

Dr Darrick Carter, Vice President - Adjuvant Technology, I.D.R.I.

Dr Sylvaine Cases, VP, Oncology Scientific Innovation, Janssen Research & Development

Dr Danilo Casimiro, VP & Head, External R&D and Vaccine Platforms, Sanofi Pasteur

Dr Christina Chambers, Professor of Pediatrics, Founding Principal Investigator of Vaccines and Medications in Pregnancy Surveillance System, University of California San Diego

Dr Amit Chaudhuri, VP of R&D, Medgenome Inc

Dr Grace Chen, Deputy Chief of the Clinical Trials Program in the VRC, National Institutes of Health

Dr James Cherry, Distinguished Research Professor of Pediatrics, Division of Infectious Diseases, David Geffen School of Medicine at Ucla

Dr Ho Cho, VP, Biotherapeutics Executive Research, Celgene

Dr Trevor Clancy, Co Founder and Chief Scientific Officer, OncoImmunity

Dr Steve Coats, Vice President External Science Strategy, MedImmune Inc

Dr Ezra Cohen, Associate Director of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Amy Conrad, Founder & CEO, Juniper Point

Dr David Crean, Managing Director, Objective Capital Partners

Dr Shane Crotty, Professor, Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology

Dr James Crowe, Director of Vanderbilt Vaccine Center, Vanderbilt Vaccine Center

Dr Stephanie Culler, Co Founder & CEO, Persephone Biome

Dr Ricardo Da Silva Antunes, Research Fellow, Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology

Dr Barry Datlof, Chief, Business Development and Commercialization, U.S. Army Medical Research and Materiel Command

Dr Daniel Deoliveira, Director of Pharmaceutical Sciences & Manufacturing, Genocea Biosciences

Dr John Desjarlais, Senior Vice President of Research and Chief Scientific Officer, Xencor, Inc.

Dr Eve Dubé, Researcher, Quebec National Institute of Public Health; Invited professor,, Universite Laval

Dr Anna Durbin, Associate Professor, Johns Hopkins Bloomberg School of Public Health

Dr Mark Esser, Senior Director, Vaccines & Infectious Diseases, Translational Medicine, MedImmune

Dr Mark Findeis, Senior Director Research Biochemistry, Agenus

Dr Bruce Gellin, President, Global Immunization, Sabin Vaccine Institute

Dr Hanspeter Gerber, Chief Scientific Officer, Eclipse Group International Ltd

Dr Hanspeter Gerber, Chief Scientific Officer, 3T Biosciences

Jeremy Gillespie, Global Sales Director, Kerry

Dr Ann Ginsberg, Senior Technical Advisor, International AIDS Vaccine Initiative (IAVI)

Dr Sergei Gleyzer, Research Associate, Department of Physics, University of Florida; Coordinator of the LHC Machine-Learning Working Group, Cern

Dr David Gorski, Managing Editor, Science Based Medicine; Professor and Chief, Breast Surgery Section, Wayne State University School of Medicine

Walter Greenblatt, Managing Director, Walter Greenblatt & Associates

Dr Alba Grifoni, Postdoctoral Fellow, La Jolla Institute for Allergy and Immunology

Dr Alba Grifoni | Postdoctoral Fellow | La Jolla Institute for Allergy and Immunology » speaking at Vaccine West Coast 2018

Dr Harry Gruber, Co-founder and President of Science and Innovation, Tocagen Inc

Dr Farshad Guirakhoo, cso, GeoVax, Inc.

Dr Swati Gupta, Vice President, Research Integration & Innovation, International Aids Vaccine Initiative

Dr Scott Halstead, Adjunct Professor, Department of Preventive Medicine and Biometrics, Immune Analytics LLC

Dr Sara Hamilton Hart, Assistant Professor, Department of Laboratory Medicine and Pathology, University of Minnesota

Drew Hannaman, Vice President of Research and Development, Ichor Medical Systems, inc

Dr Kristen Hege, Corporate Vice President, Translational Development, Hematology/Oncology, Celgene

Dr Teri Heiland, Co-Founder & Sr Vice President Research and Development, Immunomic Therapeutics

Dr Catherine Higgins, Director of Scientific Program Management, Stand Up To Cancer

Dr Stephen Hoffman, Chief Executive and Scientific Officer, Sanaria

Dr Peter Hotez, Dean, National School of Tropical Medicine, Director, Texas Children’s Hospital Center, Baylor College of Medicine

Dr Peter Jahnmatz, Research & Development, Mabtech

Dr Barbara Joyceshaikh, Project Leader, Discovery Research, Merck And Company

Dr Maria Karasarides, Executive Director, ImmunoOncology, Regeneron Pharmaceuticals

Dr Maria Karasarides | Executive Director, ImmunoOncology | Regeneron Pharmaceuticals » speaking at Vaccine West Coast 2018

Dr Rakez Kayed, Professor, Department of Neurology and Department of Neuroscience & Cell Biology, University of Texas Medical Branch

Dr Richard Kennedy, Professor of Medicine, Co-Director, Mayo Vaccine Research Group, Mayo Clinic and Foundation

Alexander Kort, SVP Corporate Development, Themis Bioscience GmbH

Dr Andrew Korytko, Lead External Innovation, Biotechnology Discovery Research, Eli Lilly and Company

Dr Christopher Larson, VP Vector Development, EpicentRx

Dr Theresa Lavallee, Head of Translational Medicine, Parker Institute for Cancer Immunotherapy

Dr Eva Lee, Professor, Center for Bioinformatics and Computational Genomics, Georgia Institute of Technology

Dr Hyam Levitsky, Former Executive Vice President and Chief Scientific Officer, Juno Therapeutics GmbH, A Celgene Company

Dr Pascal Longchamp, Chief Corporate & Commercial Officer, Scarab Genomics

Dr Paul Maffuid, EVP Research and Development, MabVax Therapeutics Inc

Dr John Mascola, Director-Vaccine Research Center, NIAID, NIH

Dr Cristian Massacesi, Vice President, Immuno-Oncology Medicine Team Leader, Pfizer

Dr Aaron Miller, Clinical Fellow, La Jolla Institute for Allergy and Immunology; Assistant Clinical Professor of Medicine, U.C. San Diego Moores Cancer Center

Dr Arturo Molina, Chief Medical Officer, Sutro Biopharma

Sandrine Miller Montgomery, Executive Director, Center for Microbiome Innovation at UC San Diego

Dr Michael Mowatt, Director, Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases

Dr Torsten Mummenbrauer, SVP Business Development, Hookipa Biotech

Dr Stephen Nagler, Executive Director, MedPro Investors LLC

Peter Nara, Chairman Emeritus, Biological Mimetics, Inc.

Dr Kim Nelson, Senior Director for Strategic Consulting, C.R.B.

Dr Michael Newman, President and CEO, Decoy Biosystems

Dr Victor Nizet, Professor of Pediatrics and Pharmacy, Chief of the Division of Host-Microbe Systems and Therapeutics, University of California San Diego

Dr Richard Pan, State Senator, California Senate, District 6

Dr Vali Papadimitrakopoulou, Professor of Medicine & Chief Thoracic Medical Oncology, National Leader Lung-MAP, The University of Texas MD Anderson Cancer Center

Dr Jason Paragas, Director, Innovation, Lawrence Livermore National Laboratory

Dr Sandip Patel, Deputy Director, San Diego Center for Precision Immunotherapy

Dr David Pyrce, Senior Vice President Of Innovation And Chief Commercial Officer, NantKwest

Dr Tony Reid, Chief Scientific Officer, EpicentRx

Dr Tony Reid | Chief Scientific Officer | EpicentRx » speaking at Vaccine West Coast 2018

Dr Paul Robbins, Senior Director of Translational Oncology, Pfizer

Dr Keith Rubin, CEO, ILiAD Biotechnologies, LLC

Dr Manish Sadarangani, Assistant Professor, Pediatric Infectious Diseases, University of British Columbia Director, Vaccine Evaluation Center, BC Children?s Hospital Research Institute

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Michael Salgaller, Supervisor, Invention Development and Marketing Unit, National Cancer Institute, National Institutes of Health

Dr Niranjan Sardesai, President & CEO, Geneos Therapeutics

Dr David Savello, Venture Advisor & Scientific Advisory Board, Pappas Ventures

Dr Melanie Saville, Director Vaccine Development, CEPI

Dr William Schief, Professor, Department of Immunology and Microbiology, The Scripps Research Institute

Dr Kirsten Schneider-Ohrum, Director, Discovery Project Leader, GSK Vaccines

Dr Raghuram Selvaraju, Managing Director, Senior Analyst, Healthcare, Rodman and Renshaw Llc

Dr Sushma Shivaswamy, Vice President, Research and Development, XBiotech

Narinder Singh, Senior Vice President of Pharmaceutical Sciences and Manufacturing, Genocea Biosciences

Dr Will Singleterry, Director of Business Development, IsoPlexis

Dr Larry Smarr, Founding Director, Calit2

Dr Larry Smarr | Founding Director | Calit2 » speaking at Vaccine West Coast 2018

Dr Trevor Smith, Director of Discovery, Preclinical, R&D, Inovio Pharmaceuticals

Ken Solovay, Chief Operating Officer, ILiAD Biotechnologies, LLC

Min Song, Program Director, Cancer Therapy Evaluation Program, Cancer Moonshot Implementation Team,, National Institutes of Health

Dr Erin Spiegel, Director of Scientific Affairs, PharmaJet

Dr Pablo Tamayo, Co-Director, Cancer Center Genomics and Computational Biology Shared Resource, Professor, Division o, University of California, San Diego (UCSD)

Dr Alexey Terskikh, Co-Founder, Stelvio Oncology

Dr Alexey Terskikh | Co-Founder | Stelvio Oncology » speaking at Vaccine West Coast 2018

Dr Seth Thomas, Head of Process Development, The Duke Human Vaccine Institute

Dr Yuan Tian, Postdoctoral Fellow, La Jolla Institute for Allergy and Immunology

Dr Yuan Tian | Postdoctoral Fellow | La Jolla Institute for Allergy and Immunology » speaking at Vaccine West Coast 2018

Dr Sangeeta Tiwari, Associate, Albert Einstein College of Medicine

Dr Steven Townson, Oncology Scientific Director, Principal Scientist, Clinical Research Oncology Early Development, Merck Research Laboratories

Dr Elizabeth Trehu, Chief Medical Officer, Jounce Therapeutics

Dr Vu Truong, CEO & CSO, Aridis Pharmaceuticals

Dr Theodore Tsai, Vice President of Immunizations science and Policy, Takeda Vaccines

Dr Sean Tucker, CSO and VP Research, Vaxart

Dr Bob Valamehr, Vice President of Cancer Immunotherapy, Fate Therapeutics

Dr Nancy Valente, Vice President, Global Product Development, Hematology/Oncology; Head Hematology Development, Genentech

Dr Gregory Wade, Managing Director, Healthcare Investment Banking, B.T.I.G.

Dr Brian Ward, Medical Officer, Medicago

Dr Daniela Weiskopf, Instructor, Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology

Dr David Whitcare, Senior Vice President, VLP Biotech

Dr Glynn Wilson, Strategic Advisor, Marker Therapeutics

Dr Travis Young, Vice President, Biologics, California Institute for Biomedical Research

Dr Maurizio Zanetti, Professor of Medicine Moores Cancer Center, University of California San Diego





Get involved

To exhibit, sponsor or speak at the event contact
Oliver Breed on +44 (0)20 7092 1156
or oliver.breed@terrapinn.com

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156


To speak:
Lauren Sheppard
+44 (0)207 092 1211